These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30880271)

  • 21. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial.
    Schwartz DL; Sosa A; Chun SG; Ding C; Xie XJ; Nedzi LA; Timmerman RD; Sumer BD
    PLoS One; 2017; 12(3):e0172055. PubMed ID: 28253270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.
    Fondevilla Soler A; López-Guerra JL; García Fernández A; Samaniego Conde MA; Belmonte González MJ; Praena-Fernandez JM; Rivin Del Campo E; Alcaraz M; Azinovic I
    Clin Transl Oncol; 2019 Jul; 21(7):881-890. PubMed ID: 30506131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.
    Bahig H; Rosenthal DI; Nguyen-Tan FP; Fuller DC; Yuan Y; Hutcheson KA; Christopoulos A; Nichols AC; Fung K; Ballivy O; Filion E; Ng SP; Lambert L; Dorth J; Hu KS; Palma D
    BMC Cancer; 2021 Apr; 21(1):446. PubMed ID: 33888069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
    Agrawal A; Moon J; Davis RK; Sakr WA; Giri SP; Valentino J; LeBlanc M; Truelson JM; Yoo GH; Ensley JF; Schuller DE;
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1044-50. PubMed ID: 17938330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
    MacKenzie R; Balogh J; Choo R; Franssen E
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Pai HH; Rochon L; Clark B; Black M; Shenouda G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial.
    Sher DJ; Avkshtol V; Moon D; Vo D; Mau T; Childs L; Lin MH; Dubas J; Ahn C; Sumer BD
    Int J Radiat Oncol Biol Phys; 2024 Jul; ():. PubMed ID: 39038521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.
    Frata P; Cellai E; Magrini SM; Bonetti B; Vitali E; Tonoli S; Buglione M; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1387-94. PubMed ID: 16115737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
    Rock K; Huang SH; Tiong A; Lu L; Xu W; Ringash J; Bratman SV; Tong L; Chan B; Cho J; Giuliani M; Hope A; Bayley A; Kim J; de Almeida JR; O'Sullivan B; Waldron J
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):941-949. PubMed ID: 29730062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
    Shimm DS; Coulthard SW
    Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
    Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
    Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer.
    Hata M; Taguchi T; Koike I; Nishimura G; Takahashi M; Komatsu M; Sano D; Odagiri K; Minagawa Y; Inoue T
    Strahlenther Onkol; 2013 Jan; 189(1):26-32. PubMed ID: 23161117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701).
    Kodaira T; Kagami Y; Shibata T; Shikama N; Nishimura Y; Ishikura S; Nakamura K; Saito Y; Matsumoto Y; Teshima T; Ito Y; Akimoto T; Nakata K; Toshiyasu T; Nakagawa K; Nagata Y; Nishimura T; Uno T; Kataoka M; Yorozu A; Hiraoka M;
    Ann Oncol; 2018 Apr; 29(4):992-997. PubMed ID: 29401241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma.
    Allal AS; Miralbell R; Lehmann W; Kurtz JM
    Radiother Oncol; 1997 Apr; 43(1):63-5. PubMed ID: 9165138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer--a feasibility study.
    O'Sullivan JM; Hollywood DP; Cody N; Dillon J; Buckney S; Moriarty MJ; Armstrong JG
    Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):236-40. PubMed ID: 12109829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.